Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Non Operating Income (2023 - 2024)

Bioregenx (BRGX) has 2 years of Non Operating Income data on record, last reported at -$67553.0 in Q3 2024.

  • For Q3 2024, Non Operating Income fell 121.7% year-over-year to -$67553.0; the TTM value through Sep 2024 reached -$522359.0, down 342.13%, while the annual FY2023 figure was -$461508.0, N/A changed from the prior year.
  • Non Operating Income reached -$67553.0 in Q3 2024 per BRGX's latest filing, down from -$66331.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $311309.0 in Q3 2023 and bottomed at -$315453.0 in Q4 2023.